Growth Metrics

Travere Therapeutics (TVTX) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -82.39%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -97.49%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -79.34%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 61.45%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -7.15%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,178.57%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn 14.89%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14.89%
Dec 31, 2025 64.29%
Sep 30, 2025 140.00%
Jun 30, 2025 84.62%
Mar 31, 2025 73.30%
Dec 31, 2024 39.66%
Sep 30, 2024 -135.53%
Jun 30, 2024 19.47%
Mar 31, 2024 -23.94%
Dec 31, 2023 -12.62%
Sep 30, 2023 280.73%
Jun 30, 2023 -7.62%
Mar 31, 2023 -18.33%
Dec 31, 2022 -22.62%
Sep 30, 2022 -84.75%
Jun 30, 2022 -64.06%
Mar 31, 2022 -25.00%
Dec 31, 2021 66.80%
Sep 30, 2021 -34.09%
Jun 30, 2021 -10.34%
Mar 31, 2021 -4,900.00%
Dec 31, 2020 -254.01%
Mar 31, 2020 102.02%
Dec 31, 2019 -297.04%
Mar 31, 2019 -115.22%
Dec 31, 2018 67.27%
Sep 30, 2018 -191.30%
Jun 30, 2018 -64.71%
Mar 31, 2018 -43.75%
Dec 31, 2017 -41.03%
Sep 30, 2017 54.00%
Jun 30, 2017 8.11%
Mar 31, 2017 -300.00%
Dec 31, 2016 -178.57%
Sep 30, 2016 -156.18%
Jun 30, 2016 49.32%
Mar 31, 2016 -106.06%
Dec 31, 2015 87.27%
Sep 30, 2015 311.90%
Jun 30, 2015 5.19%
Mar 31, 2015 140.62%
Dec 31, 2014 -34.15%
Sep 30, 2014 -18.31%
Jun 30, 2014 -87.80%